Oleanolic acid inhibits diet-induced adiposity through blocking neovascularization and macrophage accumulation involving Delta-like 4-Notch 1-nuclear factor-κB signaling Authors: Sin-Hye Park, Eunkyeong Kim, Young-Hee Kang Published: 2026 ABSTRACT AbstractBACKGROUND/OBJECTIVESObesity is a major risk factor in the pathogenesis of cardiometabolic disorders. Most of these obesity-related disorders are closely associated with vascular dysfunctions. Due to the increase of fat mass in obesity, oxygen deficiency is induced, thus developing adipose tissue vascularization. Additionally, local hypoxia generates adipokine expression and proinflammatory macrophage recruitment. This study was conducted to test efficiency of oleanolic acid on angiogenesis and proinflammation in diet-induced obese mice model.MATERIALS/METHODSC57BL/6 mice were fed 10% fat or 45% fat and treated with 10 mg/kg oleanolic acid as gavage for 20 weeks. Body weight, adipose tissue weight, and adipocyte morphology were evaluated. Angiogenesis-related signaling pathways, oxidative stress, and inflammatory markers in adipose tissue were assessed using molecular and histological analyses.RESULTSOleanolic acid decreased body weight and fat tissue weight of obese mice. Oleanolic acid inhibited diet-induced adipocyte expansion and adiposity. This natural compound reduced adipose tissue angiogenesis of obese mice through blockade of hypoxia-inducible factors 1α-vascular endothelial growth factor receptor-2 signaling and Ang-Tie2 axis. The reactive oxygen species production was reduced by oleanolic acid in fatty adipose tissues. Oleanolic acid inhibited macrophage infiltration into the adipose tissues of obese mice. Oral administration of oleanolic acid blocked Delta-like 4 (Dll4)-Notch 1-nuclear factor (NF)-κB signaling axis in adipose tissues of high fat-fed mice.CONCLUSIONThese results indicate that oleanolic acid is a potential therapeutic strategy to alleviate diet-induced adiposity at least by blocking Dll4-Notch-NF-κB signaling-associated neovascularization and macrophage inflammation in adipose tissues.Keywords: Adipogenesis, angiogenesis, DLL4, Notch1, inflammation, oleanolic acid INTRODUCTION Obesity is a major risk factor for metabolic disorders, including type II diabetes, atherosclerosis, hypertension, cardiovascular disease and cancer [1,2]. In particular, most obesity-related disorders are closely associated with vascular dysfunction [2,3,4]. Adipose tissue primarily consists of mature adipocytes and stromal vascular fraction cells, including preadipocytes, fibroblasts, endothelial cells, macrophages, and stem cells [5,6,7]. Adipose tissue is considered the largest endocrine gland producing a wide range of adipokines and growth factors, including leptin, adiponectin, resistin, vascular endothelial growth factor (VEGF), angiopoietins (Angs), and proinflammatory cytokines. These molecules play critical roles in regulating metabolic homeostasis, inflammation, and angiogenesis, and contributing to adipose tissue expansion through adipocyte hypertrophy and adipocyte progenitor cell differentiation [8,9,10]. The adipose tissue is highly vascularized, with each adipocyte supported by a capillary network that supplies oxygen and nutrients. As adipose tissue expands, continuous vascular remodeling and neovascularization are required to maintain metabolic demand [11]. The endothelial cells regulate nutrient delivery, support adipocyte progenitor growth, and contribute to adipose tissue expandability; therefore, their dysfunction is closely linked to pathological alterations in adipose tissue [6,12,13]. Specific pathological functions of vessels in adipose tissues include dysregulated angiogenesis, altered secretion of growth factors, chronic inflammation, and tissue fibrosis and remodeling [13,14]. Impaired growth factor signaling can lead to excessive adipocyte growth and tissue expansion [6,14]. In addition, dysregulation of angiogenesis can lead to a mismatch between the vascular supply and the metabolic demands of the growing adipose tissue, potentially contributing to hypoxia and further macrophage inflammation [14,15]. Understanding the pathological dysfunctions of adipose tissues are critical for developing new therapeutic approaches and targeted therapies against obesity-related pathologies. Based on genetic manipulations or pharmacological treatments with inhibitors or activators, adipose tissue angiogenesis and chronic inflammation are mechanistically linked to the comorbidities of obesity [11,14,16]. Several studies have shown that natural plant-derived compounds play important therapeutic roles in controlling obesity by influencing various metabolic pathways [17,18]. The natural compounds with adipostatic and angiostatic potential modulate factors such as VEGF and can potentially target adipose tissue expansion [11,19]. Polyphenols such as curcumin and resveratrol possess potential to reduce inflammation in adipose tissues by modulating various signaling pathways such as nuclear factor (NF)-κB, mitogen-activated protein kinases and 5′-adenosine monophosphate-activated protein kinase [20]. Oleanolic acid (Fig. 1A) is a common pentacyclic triterpenoid found widely in vegetables, medicinal herbs, and other plants [21]. Several recent reports have shown that oleanolic acid has various pharmacological properties and multiple biological effects such as hepatoprotective and anti-cancer effects [21,22]. Our previous studies demonstrated that oleanolic acid inhibited adipogenesis and inflammatory response by blocking the induction of adipogenic visfatin and resistin during adipocyte differentiation [23,24]. However, there have been no reports dealing with both anti-angiogenic and anti-inflammatory effects of oleanolic acid in adipose tissues. The current study attempted to investigate that oleanolic acid alleviated high fat diet-induced adiposity and adipogenic inflammation in adipose tissues of C57BL/6 male mice. Oleanolic acid was found to be effective at combating VEGF-mediated angiogenesis and macrophage inflammation in adipose tissues via targeting Delta-like 4 (Dll4)-Notch 1-NF-κB signaling. Chemical structure of oleanolic acid (A), animal experimental design and grouping (B), and representative images of H&E staining of mouse epididymal adipose tissues (C). C57BL/6 mice were fed 10% or 45% high-fat and orally administered 10 mg/kg oleanolic acid for 20 weeks. To observe epididymis adipocytes, H&E staining was performed with epididymal adipose tissues from each experimental animal group. Stained tissues were observed by microscopy with 200× magnification (n = 6, each of groups). Quantification of adipocyte diameter and adipose area using the ImageJ. H&E, hematoxylin and eosin. a-cRespective values in bar graphs not sharing a small letter are significantly different at P < 0.05. MATERIALS AND METHODS Chemicals Oleanolic acid and other chemicals were supplied by Sigma-Aldrich Chemicals (St. Louis, MO, USA), as were all other reagents unless specifically stated otherwise. Antibodies for VEGF, Ang-1, Ang-2, Tie-2, CD68, CD36 (scavenger receptor-B1) and NF-κB 65 were supplied by Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies for VEGF receptor-2 (VEGF-R2), CD31 and Notch1 were obtained from Cell signaling Technology (Beverly, CA, USA). Antibodies for leptin, hypoxia inducible factor (HIF)-1α were purchased from Abcam Biochemicals (Cambridge, UK). Monocyte chemoattracted protein (MCP)-1 antibody was supplied from R&D systems (Minneapolis, MN, USA) and collagen IV antibody obtained from Bioss Inc. (Woburn, MA, USA). Dll4 antibody was purchased from Invitrogen (Waltham, MA, USA). Horseradish peroxidase (HRP; Rockland Immunochemicals, PA, USA)-conjugated goat anti-rabbit immunoglobulin G (IgG), goat anti-mouse and donkey anti-goat IgG were obtained from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). β-Actin antibody was obtained from Sigma-Aldrich Chemicals. Animal experiments Wild type C57BL/6 mice (male, 3 weeks old, average body weight of 20 g) were provided by Shizuoka Prefecture Laboratory Center (Hamamatsu, Shizuoka, Japan). Mice were individually housed in cages and maintained kept on a 12-h light and dark cycle at 23 ± 1°C with 45–65% relative humidity under specific pathogen-free conditions. The mice were allowed to acclimatize for a week before commencing the experiments. All mouse experiments were performed in accordance with the University’s Guidelines for the Care and Use of Laboratory Animals approved by the Committee on Animal Experimentation of Hallym University (approval No. Hallym2011-10). Humane endpoints were established in accordance with the Institutional Animal Care and Use Committee (IACUC) guidelines. Animals were monitored daily, and euthanasia was to be performed if body weight loss exceeded 20% or if signs of severe distress were observed. No animals reached these endpoints prior to sacrifice. Mice were fed a 10% kcal fat or 45% kcal fat (Research Diets, Inc, New Brunswick, NJ, USA) for 20 weeks. The diet constituents were shown in Table 1. Animal experimental design and timeline were depicted in Fig. 1B. All mice were distributed among 4 subgroups (n = 16–20 for each subgroup; a total of 80 animals at the initial experiment); 1) mice fed 10% low fat diet, 2) mice fed 10% low fat diet and given 10 mg/kg oleanolic acid as gavage, 3) mice fed 45% high fat diet, and 4) mice fed 45% high fat diet and given 10 mg/kg oleanolic acid as gavage. Variability in subgroup sizes reflects technical issues during sample collection and storage, and analyses were conducted only on animals with complete datasets. After 20 weeks of the diet intervention, mice were sacrificed by intraperitoneal injection of 0.3 g/kg avertin and 8 µg/kg tert-amyl alcohol as approved by the IACUC protocol at the time of study (Hallym 2011-10). Following administration, animals were continuously monitored until cessation of respiration. Death was verified by absence of corneal and pedal reflexes and complete cardiac arrest, followed by cervical dislocation as a secondary physical method in accordance with American Veterinary Medical Association guidelines. Table 1Composition of animal diet ingredientsClass descriptionIngredients10% kcal fat (D12450K, g)45% kcal fat (D12451, g)ProteinCasein, lactic, 30 mesh200200Cystine, L33CarbohydrateStarch, corn55072.8Lodex10150100Sucrose, fine granulated4176.8FiberSolka floc, FCC2005050FatSoybean Oil, USP2525Lard20177.5MineralS10026B5050VitaminCholine bitartrate22V10001C11DyeDye, blue FD&C #1, Alum. lake 35–42%0.03Dye, red FD&C #40, Alum. lake 35–42%0.030.05Total1,055.05858.15Formulation of rodent diet, Research Diets, Inc. Composition of animal diet ingredients Formulation of rodent diet, Research Diets, Inc. Whole blood (approximately 0.8–1.0 mL per animal) was collected from the abdominal aorta into EDTA-coated tubes and plasma was obtained by centrifugation at 3,000 rpm for 10 min and stored at −70°C. The brown, epididymal, inguinal, retroperitoneal and visceral fat tissues were collected, frozen in liquid nitrogen, and kept at −80°C until used for Western blotting, or were preserved and fixed in 4% paraformaldehyde for immunohistochemical analyses. After the 20 week-diet intervention, the end point weight gain was shown in Table 2. The final body weight and average daily gain greatly elevated in 45% fat-fed mice, as compared to 10% fat-fed mice. High fat diet highly increased the weights of all the fat tissues by more than 2–3 times (Table 2). However, oleanolic acid reduced adipose tissue weights in mice fed 45% fat. Interestingly, oleanolic acid showed lowering effects on the weights of epididymal, retroperitoneal and visceral fat tissues in mice fed 10% fat (Table 2). The organ weights of obese mice were higher than those of lean mice (Table 2). The organ weights of obese mice were substantially reduced by oral supplementation of oleanolic acid. Table 2Basic information of animalsUnit (g)10% fat10% fat + 10 mg/kg oleanolic acid45% fat45% fat + 10 mg/kg oleanolic acidBody weightInitial weight13.444 ± 0.412a 13.333 ± 0.408a 13.444 ± 0.444a 13.444 ± 0.412a Post-20 week35.125 ± 0.434b 31.778 ± 0.521b 49.556 ± 0.377a 36.667 ± 1.014b Total gain21.6818.4436.1123.222Average day gain0.150.130.260.17Adipose tissue weightBrown0.249 ± 0.027b 0.201 ± 0.017b 0.388 ± 0.024a 0.245 ± 0.029b Epididymal1.028 ± 0.141c 0.683 ± 0.056c 2.421 ± 0.083a 1.545 ± 0.136b Inguinal0.291 ± 0.035c 0.226 ± 0.023c 0.901 ± 0.113a 0.453 ± 0.035b Retroperitoneal0.446 ± 0.034b 0.220 ± 0.022c 0.846 ± 0.068a 0.499 ± 0.039b Visceral0.551 ± 0.033b 0.399 ± 0.023c 1.361 ± 0.104a 0.531 ± 0.035b Organ weightLiver1.256 ± 0.03b 1.128 ± 0.024b 1.803 ± 0.110a 1.232 ± 0.052b Kidney0.485 ± 0.008b 0.455 ± 0.015b 0.523 ± 0.007a 0.471 ± 0.020b Pancreas0.385 ± 0.010b 0.348 ± 0.010b 0.444 ± 0.020a 0.332 ± 0.022b Spleen0.089 ± 0.003b 0.083 ± 0.003b 0.118 ± 0.006a 0.115 ± 0.003a C57BL/6 male mice (3 weeks of age) were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. Body weight was measured weekly, and food intake was daily checked by measuring the amount of provided diets and remained diet after one day. After 20 weeks of the experimental period, adipose tissues, and each organ of liver, kidney, pancreas and spleen were dissected and measured by scale. All data were analyzed with a one-way analysis of variance, followed by Duncan’s post-hoc tests.a-cRespective values (n = 16, each diet group) in the same row not sharing the same superscript differ, P < 0.05. Basic information of animals C57BL/6 male mice (3 weeks of age) were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. Body weight was measured weekly, and food intake was daily checked by measuring the amount of provided diets and remained diet after one day. After 20 weeks of the experimental period, adipose tissues, and each organ of liver, kidney, pancreas and spleen were dissected and measured by scale. All data were analyzed with a one-way analysis of variance, followed by Duncan’s post-hoc tests. a-cRespective values (n = 16, each diet group) in the same row not sharing the same superscript differ, P < 0.05. Plasma lipid analyses After 20 weeks of the diet intervention, plasma levels of total cholesterol (TC) and triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) were measured using colorimetric enzymatic assays (Asan Pharmaceuticals, Hwaseong, Korea) according to the manufacturers’ instructions. Low-density lipoprotein cholesterol (LDL-C) was determined using the formula: LDL-C = TC − (HDL-C − TG/5). Based on these values, the atherosclerosis index (AI) was obtained by using the formula: AI = (TC − HDL-C)/HDL-C. Staining with hematoxylin and eosin (H&E) A portion of epididymal fat tissues was fixed with 4% paraformaldehyde. Fat tissues were cut at 6 um thickness. After staining with Mayer’s hematoxylin for 3 min, the tissues were further stained with alcoholic eosin Y solution for 10 min. Following the dehydration steps from 95% ethanol to 100% ethanol, the stained tissues were visualized under an optical microscope (Axio Imager; Carl Zeiss, Jena, Germany) at 200× magnification. Adipocyte diameter and area were quantified using the ImageJ software. Enzyme-linked immunosorbent assay (ELISA) Mouse plasma level of VEGF (R&D System, Minneapolis, MN, USA) was determined by using ELISA kits according to the manufacturer’s instructions. Western blot analysis Western blot analysis was conducted by using adipose fat tissues prepared in 1 mM Tris-HCl lysis buffer (pH 6.8) containing 10% sodium dodecyl sulfate (SDS), 1% glycerophosphate, 0.1 mM Na3VO4, 0.5 mM NaF, and a protease inhibitor cocktail. Fat tissue extracts containing equal amounts of proteins were electrophoresed on 8–15% SDS-polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane. Blocking a nonspecific binding was performed by using either 3% fatty acid-free bovine serum albumin or 5% non-fat dry skim milk for 3 h. The membrane was incubated overnight at 4°C with a specific primary antibody of leptin, CD36, collagen IV, VEGF, HIF-1α, Ang-1, Ang-2, Tie-2, NF-κB, Dll4 and Notch 1. The membrane was then applied to a secondary antibody conjugated to HRP for 1 h. Following triple washing, the target proteins were determined by using the Immobilon Western Chemiluminescent HRP substrate (Millipore Corp., Billerica, MA, USA) and the Agfa medical X-ray film blue (Agfa HealthCare NV, Mortsel, Belgium). Incubation with β-actin or α-tubulin antibody was conducted for the comparative control. Immunohistochemical staining The paraffin-embedded fat tissues were cut at 5–6 um thickness. To enhance antigen-antibody affinity, tissue slides were permeabilized with 0.1% Triton X-100 for 10 min. To prevent non-specific antibody binding, the tissue slides were incubated in 10% fetal bovine serum for 1 h at room temperature. A specific primary antibody against HIF-1α, VEGF-R2, CD31, CD68 and MCP-1 was incubated overnight with the sectioned tissues. For the detection of HIF-1α, VEGF-R2 and CD31, the tissue sections were incubated for 1 h with green fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG or red Cy3-conjugated anti-mouse IgG. For identification of nuclei, the fluorescent nucleic acid dye of 4′,6-diamidino-2-phenylindole (DAPI; Santa Cruz Biotechnology) was applied for 10 min. Images of the stained tissues on slides were obtained with an optical microscope AxioImager system equipped for fluorescence illumination. Fluorescent FITC-CD31+ intensity and CD31-positive area was quantified by using image-based morphometry and calculated using ImageJ (National Institutes of Health, Bethesda, MD, USA). The tissue levels of CD68 and MCP-1 were detected by staining with brownish 3,3′-diaminobenzidine (DAB) or red novared. Images of the stained tissues on slides were obtained with an optical microscope Axio Imager system. Dihydroethidium (DHE) staining for reactive oxygen species (ROS) production To identify ROS deposits in adipose tissues, paraffin-embedded tissue sections (5 μm thickness) were deparaffinized and hydrated for the DHE staining. DHE exhibits blue-fluorescence in the cytosol until oxidized, where it intercalates within the cell DNA, with subsequent staining of nuclei as a bright fluorescent red. Fat tissues were stained by incubating for 1 h in 20 μM DHE (Invitrogen, Carlsbad, CA, USA). For the identification of nuclei, DAPI was given for 10 min. Stained tissues on slides were mounted in mounting solution. The DHE-stained tissue sections were observed using an optical microscope Axio Imager system for fluorescence illumination. Statistical analysis The data are presented as means ± SE of the mean for each treatment group in the in vitro and in vivo experiments. Statistical analyses were conducted by employing Statistical Analysis Systems statistical software package (IBM SPSS Statistics Version 25.0; IBM Corp., Armonk, NY, USA). Significance was determined by one-way analysis of variance, Dunnett’s test or Duncan range test for multiple comparisons. Differences were considered significant at P < 0.05. RESULTS Lipid-lowering effect of oleanolic acid This study investigated plasma lipid profiles of high fat diet-fed mice supplemented with oleanolic acid (Table 3). Plasma levels of TG, TC, LDL-C and very-low-density lipoprotein were markedly elevated in mice fed 45% fat, as compared to mice fed 10% fat. When 10 mg/kg oleanolic acid was administered to obese mice, the plasma levels of these lipids were highly reduced (Table 3). In contrast, oleanolic acid enhanced the lowered plasma HDL-C level in obese mice. Interestingly, 10 mg/kg oleanolic acid markedly improved the plasma lipid profile in mice fed 10% fat. As a result, the AI decreased in oleanolic acid -treated mice (Table 3). Table 3Serum lipid levels of animalsUnit (mg/dL)10% fat10% fat + 10 mg/kg oleanolic acid45% fat45% fat + 10 mg/kg oleanolic acidTC152.71 ± 9.10c 120.57 ± 7.10d 550.00 ± 79.73a 393.10 ± 21.53b TG141.26 ± 7.33c 64.64 ± 5.80d 720.63 ± 9.39a 466.80 ± 31.03b HDL-C23.21 ± 1.73c 40.98 ± 2.36a 6.88 ± 1.0334.32 ± 3.00b LDL-C157.75 ± 9.36c 92.51 ± 7.44d 687.25 ± 79.69a 452.14 ± 17.97b VLDL28.91 ± 2.32c 12.2 ± 1.22d 144.81 ± 8.93a 93.91 ± 8.88b AI5.72 ± 1.22c 2.22 ± 0.76d 77.82 ± 8.22a 10.56 ± 2.89b C57BL/6 male mice (3 weeks of age) were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. Plasma levels of TC, TG, and HDL-C, and the LDL-C level was calculated by formulas. Equation: LDL-C= TC − (HDL-C − TG/5), VLDL = TG/5, and AI = (TC − HDL-C)/HDL-C. All data were analyzed with a one-way analysis of variance, followed by Duncan’s post-hoc tests.TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL, very-low-density lipoprotein; AI, atherosclerosis index.a-dRespective values (n = 16, each diet group) in the same row not sharing the same superscript differ, P < 0.05. Serum lipid levels of animals C57BL/6 male mice (3 weeks of age) were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. Plasma levels of TC, TG, and HDL-C, and the LDL-C level was calculated by formulas. Equation: LDL-C= TC − (HDL-C − TG/5), VLDL = TG/5, and AI = (TC − HDL-C)/HDL-C. All data were analyzed with a one-way analysis of variance, followed by Duncan’s post-hoc tests. TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL, very-low-density lipoprotein; AI, atherosclerosis index. a-dRespective values (n = 16, each diet group) in the same row not sharing the same superscript differ, P < 0.05. Histological changes in adipose tissues This study examined whether oleanolic acid inhibited adipose tissue hypertrophy morphometrically. As shown in Fig. 1C, the adipocytes in the 45% fat-fed mice were larger on average in diameter and area. In contrast, treatment with 10 mg/kg oleanolic acid resulted in a significant reduction in the mean adipocyte diameter and area. Notably, oleanolic acid per se reduced the adipocyte area even in 10% fat-fed lean mice. However, there was neither adipocyte hypertrophy nor hyperplasia observed, compared to abnormal enlargement of fat cells in high fat diet-fed mice. Inhibition of adiposity-related biomarkers by oleanolic acid in adipose tissues An in vivo study revealed that oleanolic acid influenced the tissue levels of adiposity-related biomarkers in obese mice. Adipose tissue levels of the adipokine leptin were highly elevated in obese mice due to increased fat mass (Fig. 2A). Such induction of leptin in adipose tissues was attenuated in oleanolic acid-treated, high fat diet-fed mice. Inhibitory effects of oleanolic acid on induction of adiposity-related leptin, CD36 and collagen IV in mouse fat tissues. C57BL/6 mice were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. Fat tissue extracts were subjected to Western blot analysis with a primary antibody against leptin (A), CD36 (B) or collagen IV (C). β-Actin protein was used as an internal control. The bar graphs (n = 3, each of animal groups) represent quantitative results of blots obtained from a densitometer. a-cRespective values in bar graphs not sharing a small letter are significantly different at P < 0.05. The CD36 is a marker of adipocyte progenitors with adipogenic potential, most probably by facilitating lipid uptake [25]. The CD36 induction was observed in the adipose tissues of mice fed 45% fat, whereas oral treatment of 10 mg/kg oleanolic acid reduced its induction (Fig. 2B). It should be noted that 10% fat feeding did not induce the leptin and CD36 in adipose tissues. It can be assumed that high fat diet induced hyperplasic adiposity as well as hypertrophic obesity. Oleanolic acid did not induce leptin and CD36 in adipose tissues of 10% fat-fed mice (Fig. 2A and B). In pathological conditions such as obesity, the accumulation of large collagen bundles results in adipose tissue fibrosis, disturbing the adipose tissue functions [26]. This study further examined that high fat diet increased collagen formation in mouse adipose tissues, which was inhibited by oral administration of 10 mg/kg oleanolic acid. The adipose tissue level of collagen IV highly increased in obese mice (Fig. 2C). However, such increase was reduced in oleanolic acid-treated mice, most likely inhibiting diet-induced adipogenic fibrosis. Suppressive effects of oleanolic acid on HIF-1α induction and oxidant formation This study examined whether high fat induced the expression of proangiogenic HIF-1α in adipose tissues, which was disrupted by treating oleanolic acid. High fat enhanced the adipose tissue level of HIF-1α, while this level was diminished in oleanolic acid-treated obese mice (Fig. 3A). In addition, the red Cy3-immunohistochemical staining revealed that oleanolic acid diminished the HIF-1α induction in the fat tissues of high fat diet-fed mice (Fig. 3B). Accordingly, the feeding of high fat diet stimulated adipose tissue angiogenesis in a hypoxic milieu, which was antagonized by treating oleanolic acid in obese mice. Suppression of HIF-1α induction in mouse fat tissues supplemented with oleanolic acid. C57BL/6 mice were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. Fat tissue extracts were subjected to Western blot analysis with a primary antibody against HIF-1α (A). β-Actin protein was used as an internal control. The bar graphs (n = 3, each of groups) represent quantitative results of blots obtained from a densitometer. For the measurements of the HIF-1α level (B), histological sections of mouse adipose tissues were immunohistochemically stained using a primary antibody of HIF-1α. The HIF-1α level was identified as red-Cy3. The sections were counter-stained with blue DAPI. Inhibition of ROS production in high fat-exposed mouse adipose tissues (C). Tissue sections were stained with DHE, and nuclear staining was done with DAPI. Fluorescent DHE intensity for ROS production was quantified. Each photograph is representative of 4 mice (magnification: 200×). HIF, hypoxia inducible factor; DAPI, 4′,6-diamidino-2-phenylindole; ROS, reactive oxygen species; DHE, dihydroethidium. a-dRespective values in bar graphs not sharing a small letter are significantly different at P < 0.05. ROS generation is increased in obesity due to excess nutrient intake and adipose tissue dysfunction, which can, in turn, promote adipogenesis and contribute to insulin resistance, a hallmark of obesity [27]. This study introduced DHE staining for ROS production in adipose tissues from mice exposed to high fat diet. There was a strong DHE staining in adipose tissues of obese mice, indicating marked ROS production by high fat (Fig. 3C). However, oral administration of 10 mg/kg oleanolic acid highly attenuated ROS production in adipose tissues of high fat diet-fed mice. Thus, it can be assumed that oleanolic acid was effective in diminishing oxidative stress during adipogenesis in high fat diet-fed mice. Blockade of VEGF induction by oleanolic acid in adipose tissues An in vivo study showed that high fat diet increased the plasma level of proangiogenic VEGF in the circulation (Fig. 4A). When 10 mg/kg oleanolic acid was orally administered to obese mice, the VEGF-1 level was restored to the level observed in mice fed a low fat diet. It should be noted that oleanolic acid did not influence the systemic VEGF-1 levels, significantly (Fig. 4A). The VEGF-R2 trafficking and signaling play a role in adipogenesis and adipose tissue function [28,29]. The VEGF induction was enhanced in adipose tissues of high fat diet-fed mice, whereas the oral administration of oleanolic acid attenuated such induction (Fig. 4B). Furthermore, this study attempted to confirm that oleanolic acid highly inhibited the induction of adipose tissue VEGF-R2 in high fat diet-fed mice, as evidenced by green FITC-immunohistochemical staining (Fig. 4C). Inhibitory effects of oleanolic acid on VEGF and VEGF-R2 levels in obese mice. C57BL/6 mice were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. Plasma level of soluble VEGF was determined by using a commercial ELISA kit (A). Fat tissue extracts were subjected to Western blot analysis with a primary antibody against VEGF (B). β-Actin protein was used as an internal control. The bar graphs (n = 3, each of groups) represent quantitative results of blots obtained from a densitometer. For the measurements of the VEGF-R2 level, histological sections of mouse adipose tissues were immunohistochemically stained using a primary antibody of VEGF-R2. The VEGF-R2 level was identified as green-FITC (C). The sections were counter-stained with blue DAPI (magnification: 200×). VEGF, vascular endothelial growth factor; VEGF-R2, vascular endothelial growth factor receptor 2; ELISA, enzyme-linked immunosorbent assay; FITC, fluorescein isothiocyanate; DAPI, 4′,6-diamidino-2-phenylindole. a,bRespective values in bar graphs not sharing a small letter are significantly different at P < 0.05. Inhibitory effect of oleanolic acid on neovascularization and Ang induction To examine whether oleanolic acid inhibited neovascular formation in fatty adipose tissues, the CD31 induction was measured by immunohistochemical analysis with FITC. The endothelial marker CD31 was highly induced in fatty adipose tissues, indicating a marked endothelial formation (Fig. 5A and B). In contrast, the green FITC-staining showed that the oral administration of 10 mg/kg oleanolic acid reduced vascular formation in adipose tissues. Inhibitory effects of oleanolic acid on induction of the angiogenic markers of Ang-1, Ang-2 and Tie-2 in mouse adipose tissues. (A) C57BL/6 mice were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. For the detection of CD31 level, histological sections of mouse adipose tissues were immunohistochemically stained using a primary antibody of CD31. (B) The CD31 level was identified as green-FITC. The sections were counter-stained with blue DAPI (magnification: 200×). Fluorescent FITC-CD31+ intensity and CD31-positive area was quantified and normalized to DAPI-positive area, expressed as CD31-positive area fraction (%). Fat tissue extracts were subjected to Western blot analysis with a primary antibody against (C) Ang-1, Ang-2 and (D) Tie-2. β-Actin protein was used as an internal control. The bar graphs (n = 3, each of groups) represent quantitative results of blots obtained from a densitometer. Ang, angiopoietin; FITC, fluorescein isothiocyanate; DAPI, 4′,6-diamidino-2-phenylindole. a-dRespective values in bar graphs not sharing a small letter are significantly different at P < 0.05. The endothelial Ang-Tie receptor pathway regulates vascular homeostasis, and controls vessel permeability, inflammation and angiogenic responses [30]. This study examined whether the Ang-Tie-2 pathway was stimulated in fatty mouse adipose tissues. The vascular induction of Ang-1 and Ang-2 in adipose tissues was markedly promoted by feeding high fat diet to mice (Fig. 5C). In contrast, such induction was inhibited by oral treatment of oleanolic acid to obese mice. Additionally, the adipose tissue level of Tie-2 was enhanced in high fat-fed mice and was reduced by administrating oleanolic acid (Fig. 5D). It can be assumed that the Ang-Tie pathway may play a role in diet-induced adipogenesis and angiogenic dysfunction. Accordingly, oleanolic acid inhibited angiogenesis in adipose tissues by disturbing Ang-Tie axis signaling required for formation of new blood vessels in the presence of VEGF. Inhibition of inflammation by oleanolic acid in adipose tissues The current study investigated that high fat diet caused inflammation in adipose tissues, which was attenuated by oral treatment with10 mg/kg oleanolic acid. Adipose tissues were immunohistochemically stained with CD68 antibody and MCP-1 antibody against macrophages. Compared to those of mice fed 10% fat, the macrophage markers of CD68 and MCP-1 were highly expressed in adipose tissues (arrows, Fig. 6). Accordingly, high fat diet increased macrophage infiltration into the adipose tissues, leading to inflammatory process or adiposity. On the other hand, the DAB-staining showed that the oral administration of 10 mg/kg oleanolic acid reduced its induction in adipose tissues of obese mice. In addition, the induction of novared-stained MCP-1 was diminished in fatty adipose tissues (Fig. 6). Inhibition of inflammatory responses in mouse fat tissue supplemented with oleanolic acid. C57BL/6 mice were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. For the measurements of the levels of CD68 and MCP-1, histological sections of mouse adipose tissues were immunohistochemically stained using a primary antibody of CD68 or MCP-1. The CD68 level was identified as a brown staining of DAB, and the MCP-1 level was measured with a novared-red staining. Each photograph is representative of 4 mice (magnification: 200×). MCP, monocyte chemoattracted protein; DAB, 3,3′-diaminobenzidine. Interruption of Dll4-Notch signaling by oleanolic acid in adipose tissues The Dll4-mediated Notch signaling is involved in inflammatory responses and regulation of blood vessel formation [31,32]. When mice were fed 45% fat, Dll4 and Notch 1 were highly induced in adipose tissues (Fig. 7A and B). In addition, the activation of NF-κB was observed in adipose tissues of obese mice (Fig. 7C). However, the induction and activation of Dll4, Notch 1 and NF-κB in adipose tissues were attenuated by oral administration of 10 mg/kg oleanolic acid to obese mice. Accordingly, it can be assumed that oleanolic acid combated proinflammatory responses and neovessel formation in fat tissues through blocking the Dll4-mediated Notch-NF-κB axis signaling. Blockade of Dll4-Notch-NF-κB signaling in mouse fat tissue supplemented with oleanolic acid. C57BL/6 mice were fed 10% or 45% lard fat and orally administrated 10 mg/kg oleanolic acid for 20 weeks. Fat tissue extracts were subjected to Western blot analysis with a primary antibody against (A) Dll4, (B) Notch 1 or (C) NF-κB. β-Actin protein was used as an internal control. The bar graphs (n = 3, each of groups) represent quantitative results of blots obtained from a densitometer. Dll4, Delta-like 4; NF, nuclear factor. a-cRespective values in bar graphs not sharing a small letter are significantly different at P < 0.05. DISCUSSION Eight major findings were extracted from this study of oleanolic acid: 1) Oral administration of oleanolic acid diminished adipocyte size, inhibiting high fat diet-induced adipocyte hypertrophy and hyperplasia; 2) Oleanolic acid inhibited the induction of adiposity-related leptin, CD36 and collagen IV elevated in fatty adipose tissues; 3) When oleanolic acid was treated to obese mice, the level of VEGF in the circulation and adipose tissues was reduced; 4) Oleanolic acid suppressed the adipose tissue levels of HIF-1α and VEGF-R2 in high fat diet-fed mice, which was accompanied by reduced CD31-positive endothelial area in adipose tissues; 5) Oral treatment of oleanolic acid blocked the induction of angiogenic Ang-Tie-2 axis in fatty adipose tissues; 6) Oleanolic acid highly reduced ROS production in adipose tissues of high fat-fed mice, diminishing oxidative stress during high fat diet-induced adipogenesis; 7) In adipose tissues of high fat diet-fed mice treated with oleanolic acid, the induction of proinflammatory CD68 and MCP-1 was markedly attenuated; and 8) Oral administration of oleanolic acid disturbed the signaling axis of Dll4-Notch 1-NF-κB in adipose tissues of high fat-fed mice. Therefore, oleanolic acid may be a potential agent combating diet-induced adiposity, adipogenic angiogenesis and macrophage inflammation, possibly interfering with Dll4-Notch 1-NF-κB signaling. Adipose tissue expansion through hypertrophy or hyperplasia requires vascular remodeling that involves new vessel formation [14,15,33]. High fat feeding induces angiogenesis in skeletal muscle and activates angiogenic pathways in capillaries [33]. Consistently, this study showed that 45% fat diet caused hypertrophic adipose tissue expansion. In addition, high fat feeding increased adipose tissue level of CD36, a marker of adipocyte progenitors with adipogenic potential, inducing adipocyte hyperplasia and facilitating lipid uptake. Increasing evidence demonstrates that impaired angiogenesis can lead to dysfunctional adipose tissues and contribute to metabolic diseases in individuals with obesity [11,34,35]. Several studies suggest that dysregulated angiogenesis prevents proper blood supply and oxygen delivery to adipose tissues, leading to hypoxia, inflammation, and cell death [15,36]. The current study revealed that high fat feeding enhanced the ROS production in adipose tissues. Decreased oxygen supply or increased relative oxygen consumption in the adipose tissues results in adipose tissue hypoxia [36]. In obese adipose tissues the HIF-1α level was highly enhanced with marked induction of angiogenic VEGF and Ang proteins, facilitating the fat mass expansion in adipose tissues. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodeling of the adipose tissue vasculature [34,35]. Therefore, pharmacological manipulation of adipose tissue angiogenesis might offer a novel therapeutic option for the treatment of obesity and related metabolic disorders [11]. Vasculature-adipose tissue interaction is a key mechanism for pathological inflammation in obesity. Endothelial activation reflects proinflammatory status of hypertrophic adipocytes in obesity, which promotes chronic inflammation [14,37]. Dysregulated angiogenesis is thought to play a role in inducing inflammatory activation of the excessively expanding white adipose tissues [14]. On the contrary, inflammation can trigger angiogenesis, in which newly formed blood vessels can, in turn, aggravate inflammation through a positive feedback loop [38]. Accordingly, angiogenesis and inflammation are closely interconnected processes, particularly in pathological conditions. This study showed that CD68 and MCP-1 were induced in adipose tissues of obese mice exposed to high fat, indicating that lipid-rich macrophages were accumulated with activation of inflammatory responses. Unresolved inflammation is a dominant contributor to the pathogenesis of dysfunctional adipose tissues in obesity [39]. In addition, inflammation can drive inappropriate extracellular matrix remodeling and fibrosis, which can stimulate migration of immune cells into adipose depots and exacerbate inflammation in adipose tissues [38]. High fat diet enhanced the collagen IV level in adipose tissues, most likely inducing adipose fibrosis. Preexisting adipose dysfunction can be corrected via inhibition of angiogenic action of VEGF and ablation of proinflammatory adipocytes [40]. Targeting adipose tissue angiogenesis with pharmacological manipulations represents potentially promising strategies to treat obesity and its comorbidities [14]. In addition, therapeutic interventions that reduce adipose tissue inflammation provide an approach to combat comorbidities of obesity [41,42]. Natural alternatives like plant-source compounds may constitute potent therapies for adipose tissue inflammation linked to obesity [41]. Oleanolic acid attenuated hypertrophic and hyperplasic adiposity through inhibiting adipose tissue induction of leptin and CD36 in obese mice. In addition, this natural compound suppressed hypoxia-associated neovascularization in fatty adipose tissues through blocking HIF-1α-VEGF signaling and inhibiting induction of Ang proteins. Furthermore, certain therapies are targeting immune cells, signaling pathways and adipocyte cytokines involved in inflammatory responses [42]. The macrophage infiltration into adipose tissues contributes to obesity-induced inflammation and insulin resistance, making them a promising target for therapeutic interventions [42,43]. This study demonstrated that oleanolic acid inhibited activation of NF-κB pathway, thereby reducing macrophage accumulation in fatty adipose tissues. Similarly, one study shows that oleanolic acid improves obesity-related inflammation and insulin resistance by regulating mitochondrial function and macrophage activation [44]. Adipocytes communicate with the neighboring endothelium through several mechanisms [14]. The VEGF-VEGF-R2 trafficking play a role in adipocyte differentiation and adipose tissue function in a paracrine manner [28]. A reciprocal regulation is present between adipogenesis and angiogenesis, suggesting that blockade of VEGF signaling can inhibit adipose tissue formation [27]. One study shows that oleanolic acid inhibits VEGF-R2 signaling in endothelial cells, implying anti-angiogenic therapy [45]. Similarly, this study revealed that oleanolic acid blocked HIF-1α-VEGF-R2-Ang signaling in hypertrophic and hyperplasic adipose tissues of obese mice fed high fat. On the other hand, it has been shown that the Dll4-mediated Notch signaling is involved in regulation of blood vessel sprouting and branching during normal and pathological angiogenesis [31,32]. Growing evidence shows that Dll4-Notch signaling is closely linked to the VEGF pathway, with VEGF regulating Dll4 induction and Notch signaling influencing induction of VEGF receptor [46]. Consistently, this study demonstrated that Dll4-Notch1 signaling was increased with diet-induced neovascularization and adiposity, having potential as a therapeutic target. In addition, oleanolic acid blocked the induction of Dll4 and Notch1, with inhibition of VEGF-R2 induction and Ang-Tie2 signaling. Dll4-Notch signaling is implicated in regulating inflammatory responses, particularly in immune cells like macrophages [31,47]. Blockade of Dll4 suppressed macrophage accumulation and the expression of MCP-1 in adipose tissues [48]. Similarly, the inhibition of Dll4 by oleanolic acid alleviated inflammation by disturbing Notch signaling in inflamed adipose tissues. Thus, the Dll4-Notch 1 axis may be one of the shared mechanisms of oleanolic acid for diet-induced adiposity, serving as a potential therapeutic target for ameliorating obesity. In summary, the current study investigated that oral administration of oleanolic acid combated diet-induced obesity. Oleanolic acid inhibited high fat-induced adipocyte expansion and adiposity by suppressing the induction of leptin, CD36 and collagen IV. This natural compound reduced adipose tissue angiogenesis of obese mice through blockade of HIF-1α-VEGF-R2 signaling and Ang-Tie2 axis. The ROS production was reduced by oleanolic acid in high fat-induced adiposity. Oleanolic acid inhibited the macrophage accumulation and proinflammatory responses in adipose tissues of obese mice. In addition, oral administration of oleanolic acid appeared to inhibit Dll4-Notch 1-NF-κB signaling axis in adipose tissues of high fat-fed mice. Therefore, possible inhibition of Dll4-Notch 1-NF-κB signaling by oleanolic acid merits evaluation as a novel therapeutic target for diet-induced obesity, targeting excess angiogenesis and proinflammation in adipose tissues. Although causal relationships cannot be established from this single time-point analysis, these findings suggest that oleanolic acid modulates vascular inflammation-associated pathways in adipose tissues during diet-induced obesity. Furthermore, it is necessary to determine macrophage polarization status in oleanolic acid-treated fatty adipose tissues. Footnotes Funding: This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (RS-2021-NR060133) and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (RS-2025-00520209). Conflict of Interest: The authors declare no potential conicts of interests. Author Contributions: Conceptualization: Park SH, Kang YH.Data curation: Park SH, Kim E.Formal analysis: Park SH, Kang YH.Investigation: Park SH, Kim E.Methodology: Park SH, Kang YH.Project administration: Kang YH.Supervision: Kang YH.Writing - original draft: Park SH, Kang YH.Writing - review & editing: Park SH, Kim E, Kang YH. Conceptualization: Park SH, Kang YH. Conceptualization: Park SH, Kang YH. Data curation: Park SH, Kim E. Data curation: Park SH, Kim E. Formal analysis: Park SH, Kang YH. Formal analysis: Park SH, Kang YH. Investigation: Park SH, Kim E. Investigation: Park SH, Kim E. Methodology: Park SH, Kang YH. Methodology: Park SH, Kang YH. Project administration: Kang YH. Project administration: Kang YH. Supervision: Kang YH. Supervision: Kang YH. Writing - original draft: Park SH, Kang YH. Writing - original draft: Park SH, Kang YH. Writing - review & editing: Park SH, Kim E, Kang YH. Writing - review & editing: Park SH, Kim E, Kang YH. References